SAVA 43.3% short cost to borrow over 100% now

43.3% short cost to borrow over 100% now

Loaded s bunch of NVAX, SAVA & SLS

NVAX is going to move here within a week imo

Looks ripe!

News soon Miami Gent...

NVAX Gap filled at $16.75

HOLX load zone, NVAX load em $12.75-13.15

https://www.fool.com/investing/2024/05/17/could-novavax-become-the-next-moderna/?source=webull&utm_source=webull&utm_medium=feed&utm_campaign=article

NVAX BOOM!

Things about to get interesting at NVAX...

http://archive.fast-edgar.com/20240508/AJ2ZM222U222R2Z2222E22ERKLRSZ222L562

Things about to get interesting at NVAX...

http://archive.fast-edgar.com/20240508/AJ2ZM222U222R2Z2222E22ERKLRSZ222L562

NVAX in Play. Big move coming...

NVAX a takeover target...
https://www.pharmavoice.com/news/novavax-activist-investor-pfizer-shah/715045/

NVAX a takeover target...
https://www.pharmavoice.com/news/novavax-activist-investor-pfizer-shah/715045/

LOL...You are good person BR. You deserve the best of luck!

https://finance.yahoo.com/news/inovio-announces-pricing-approximately-36-223900148.html

https://finance.yahoo.com/news/inovio-announces-pricing-approximately-36-223900148.html

BTI & MO cheap buys here

JNJ, PFE, BMY all cheap

INTC $33.85 is the support. They need a new CEO like PFE.

0.000001 ????LMAO

Where is Bobby? Did he sell out?

Novavax: Implied upside of 600%
The comeback story of the year, at least based on the price target of one Wall Street analyst, may be biotech stock Novavax (NVAX 0.62%). Despite tumbling more than 98% from its all-time high, H.C. Wainwright analyst Vernon Bernardino foresees shares of Novavax catapulting to $35. This would represent a 600% increase from the $5 shares closed at on Jan. 5.

Perhaps the biggest pendulum swing for Novavax is pending arbitration concerning orders for its COVID-19 vaccine with Gavi, a nongovernmental global vaccine organization. Gavi is seeking $700 million following the cancellation of a contract with Novavax for 350 million doses of its COVID-19 vaccine. If Novavax owes nothing, its financial foundation would be greatly improved. Meanwhile, if it has to pay $700 million to Gavi, its ability to continue as a solvent company may come into question.

Cost-cutting is another big catalyst in 2024 for Novavax. The company practically halved its operating expenses through the first nine months of 2023 -- a $950 million reduction when compared to the comparable period in 2022 -- and has plans to slash another $300 million in full-year costs in the new year. If Novavax can meet these aggressive cost-cutting goals, it should meaningfully reduce its rate of cash burn.

The other wild card here is figuring out what happens with COVID-19 vaccine demand. Novavax used traditional methods to develop a protein-based vaccine, which is markedly different than the messenger-RNA vaccines developed by Moderna and Pfizer/BioNTech. If Novavax were to see stronger demand for its COVID-19 vaccine, or gather momentum as it kicks off late-stage studies for a combination vaccine (influenza and COVID-19), it's possible shares could enjoy significant upside in the new year. While I'm not nearly as bullish on Novavax as Bernardino, a triple-digit gain could be in the cards in 2024 if things fall Novavax's way.

Novavax: Implied upside of 600%
The comeback story of the year, at least based on the price target of one Wall Street analyst, may be biotech stock Novavax (NVAX 0.62%). Despite tumbling more than 98% from its all-time high, H.C. Wainwright analyst Vernon Bernardino foresees shares of Novavax catapulting to $35. This would represent a 600% increase from the $5 shares closed at on Jan. 5.

Perhaps the biggest pendulum swing for Novavax is pending arbitration concerning orders for its COVID-19 vaccine with Gavi, a nongovernmental global vaccine organization. Gavi is seeking $700 million following the cancellation of a contract with Novavax for 350 million doses of its COVID-19 vaccine. If Novavax owes nothing, its financial foundation would be greatly improved. Meanwhile, if it has to pay $700 million to Gavi, its ability to continue as a solvent company may come into question.

Cost-cutting is another big catalyst in 2024 for Novavax. The company practically halved its operating expenses through the first nine months of 2023 -- a $950 million reduction when compared to the comparable period in 2022 -- and has plans to slash another $300 million in full-year costs in the new year. If Novavax can meet these aggressive cost-cutting goals, it should meaningfully reduce its rate of cash burn.

The other wild card here is figuring out what happens with COVID-19 vaccine demand. Novavax used traditional methods to develop a protein-based vaccine, which is markedly different than the messenger-RNA vaccines developed by Moderna and Pfizer/BioNTech. If Novavax were to see stronger demand for its COVID-19 vaccine, or gather momentum as it kicks off late-stage studies for a combination vaccine (influenza and COVID-19), it's possible shares could enjoy significant upside in the new year. While I'm not nearly as bullish on Novavax as Bernardino, a triple-digit gain could be in the cards in 2024 if things fall Novavax's way.

INO moving prior to RS decision on the 12th. NVAX time to load up. SPWR roll the dice before the 19th?

What a scam. CEO should be put in jail.

INO....BLA FROM THE FDA
https://www.prnewswire.com/news-releases/inovio-receives-fda-feedback-that-data-from-completed-phase-12-trial-of-ino-3107-can-be-used-to-submit-a-bla-under-accelerated-approval-program-301951543.html

NVAX...time to buy

https://www.cnbc.com/2023/10/07/novavax-covid-vaccine-can-still-catch-up-to-pfizer-moderna-shots.html

HOW MANY SHARES DID THEY DUMO INTO THE FLOAT? CEO is a thug, imo

Load NVAX $7's and low 8's IMO.

I like the way NVAX is trading and has a low float and a huge short interest over 40%

??? Are you speaking to yourself? Man, INOVIO has you one foot inside the nut house!

Learn how to truly trade? LMAO

Thanks for the advice.

Why? I'm down on my trade and waiting. If it doesn't pan out, oh well! I made a nice profit on INO in 2020 so I does not matter what happens. I like the technology and the partners they are currently involved with. I will move on if it can't make it to the finish line, unlike you.

How does the CEO Reverse spilt the stock and drive it back down to .077? He unloaded the 400M authorized again? He is laughing at the share holders as he rides his bike down the minuteman rail trail everyday. Maybe he will write another book?

Serious Miami, you need a life. Very sad you are still hung up on Inovio and Avtar Dhillon(BTW has Zero to do with INO currently). Sounds like you lost a lot of $$$ and have an axe to grind.

Father of The Inovio Scam Expose??? OMG LOL

You should find a hobby, imo.

Best of luck!

Again, you make no sense. They are compensated in cash and stock. Why wouldn't someone want a seat on the BOD for INO? I have converted restricted stock with my prior employer and took the cash because I had to. My choice. Had zero to do with any thing else. You are hung up on a $5700 transaction which shows how over focused you are on the company.

What happened in the past is the past. Stop looking in the rear view mirror for Avtar Dhillon because he could care less who you are. BTW: He has zero to do with INO currently.

INO Insider selling at fifty six cents is a real tell???? This is how she is compensated. What do you expect her to do? Sell the shares INO provides for her service to the BOD.